New (Image 1)
Sitagliptin Tablet, Film Coated
Product Images NDC 0480-2607
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin (NDC 0480-2607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
2 (Image 3)
25mg, 30ct (Image 4)
This is a product description for Sitagliptin tablets. Each film-coated tablet contains Sitagliptin 25mg, which is equivalent to 25mg of Stagipan. The tablets are to be stored at 20°C to 25°C (68°F to 77°F) and dispensed by a pharmacist. The medication is manufactured by Watson Pharma Private Limited in India and is distributed by Teva Pharmaceuticals in the United States.*
50mg, 30ct (Image 5)
100mg, 30ct (Image 6)
Sitagliptin tablets are a pharmaceutical product with a dosage of 100 mg. These tablets are prescribed to patients and come with a Medication Guide. Each tablet contains 128.5 mg of Sitagliptin phosphate and should be stored at a temperature between 20°C to 25°C. The tablets are produced by Watson Pharma in Goa, India, and manufactured for Teva Pharmaceuticals in Parsippany. The GTIN code for the product is 0304802609561.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
